A) SLE patients vs. healthy controls | ||||||
Gene | Mean (95% CI) | P value | ||||
Controls | SLE | |||||
TLR1 | 0.0482 (0.005‒0.107) | 0.053 (0.006‒0.176) | 0.599 | |||
TLR2 | 0.039 (4.75 × 10− 5‒0.208) | 0.040 (1.7 × 10− 4‒0.213) | 0.590 | |||
TLR3 | 0.002 (2.51 × 10− 5‒0.017) | 0.0009 (2.46 × 10− 5‒0.013) | 0.122 | |||
TLR4 | 0.044 (0.008‒0.118) | 0.081 (0.011‒0.503) | 0.012* | |||
TLR5 | 0.021 (3.94 × 10− 5‒0.76) | 0.020 (2.81 × 10− 5‒0.103) | 0.976 | |||
TLR6 | 0.03 (6.4 × 10− 4‒0.117) | 0.041 (0.004‒0.230) | 0.323 | |||
TLR7 | 0.014 (1.56 × 10− 4 ‒0.039) | 0.019 (6.63 × 10− 5‒0.104) | 0.655 | |||
TLR8 | 0.043 (0.004‒0.190) | 0.047 (2.42 × 10− 4‒0.241) | 0.682 | |||
TLR9 | 0.010 (2.5 × 10− 5‒0.022) | 0.012 (4.69 × 10− 5‒0.073) | 0.408 | |||
TLR10 | 0.009 (5.0 × 10− 4‒0.022) | 0.006 (2.71 × 10− 5‒0.430) | 0.0007* | |||
B) Active LN-SLE vs. Inactive LN-SLE vs. No LN-SLE Patients | ||||||
Gene | Mean (95% CI) | P value | ||||
Active LN-SLE | Inactive LN-SLE | No LN-SLE | Active vs. Inactive LN-SLE | Active vs. No LN SLE | Inactive vs. No LN SLE | |
TLR1 | 0.061 (0.017‒0.094) | 0.044 (0.007‒0.102) | 0.051 (0.006‒0.175) | 0.087 | 0.194 | 0.377 |
TLR2 | 0.078 (0.007‒0.213) | 0.041(0.002‒0.088) | 0.030 (1.6 × 10− 4‒0.117) | 0.291 | 0.009* | 0.066 |
TLR3 | 5.7 × 10− 4(5.7 × 10− 5‒0.003) | 6.4 × 10− 4(2.9 × 10− 5‒0.002) | 0.001 (2.5 × 10− 5‒0.014) | 0.545 | 0.567 | 0.603 |
TLR4 | 0.076 (0.033‒0.147) | 0.06 (0.011‒0.261) | 0.079 (0.015‒0.325) | 0.077 | 0.269 | 0.544 |
TLR5 | 0.035 (1.2 × 10− 4‒0.103) | 0.02(2.8 × 10− 5‒0.070) | 0.017 (4.7 × 10− 5‒0.102) | 0.202 | 0.037* | 0.883 |
TLR6 | 0.039 (0.015‒0.097) | 0.055 (0.014‒0.23) | 0.036 (0.004‒0.168) | 0.936 | 0.134 | 0.171 |
TLR7 | 0.017 (0.006‒0.039) | 0.022(0.005‒0.06) | 0.0188 (6.6 × 10− 5‒0.241) | 0.599 | 0.344 | 0.383 |
TLR8 | 0.050 (0.008‒0.096) | 0.051 (0.012‒0.714) | 0.041 (2.4 × 10− 4‒0.039) | 0.687 | 0.101 | 0.136 |
TLR9 | 0.017 (6.5 × 10− 5‒0.061) | 0.017 (0.003‒0.073) | 0.009 (4.7 × 10− 5‒0.39) | 0.676 | 0.142 | 0.019* |
TLR10 | 0.007 (6.5 × 10− 5‒0.017) | 0.005 (2.5 × 10− 4‒0.02) | 0.006 (2.7 × 10− 5‒0.061) | 0.467 | 0.273 | 0.777 |
C) CNS-SLE vs. No CNS-SLE patients | ||||||
Gene | Mean (95% CI) | P value | ||||
CNS-SLE | No CNS-SLE | |||||
TLR1 | 0.088 (0.038‒0.150) | 0.048 (0.006‒0.176) | 0.0199* | |||
TLR2 | 0.020 (4.0 × 10− 4‒0.083) | 0.041 (1.6 × 10− 4‒0.213) | 0.0986 | |||
TLR3 | 3.36 × 10− 4 (7.9 × 10− 5‒5.9 × 10− 4) | 0.001 (2.46 × 10− 5‒0.014) | 0.8946 | |||
TLR4 | 0.173 (0.084‒0.295) | 0.066 (0.011‒0.325) | 0.0003* | |||
TLR5 | 0.008 (0.002‒0.014) | 0.022 (2.81 × 10− 5‒0.104) | 0.3839 | |||
TLR6 | 0.087 (0.025‒0.168) | 0.036 (0.004‒0.23) | 0.0070* | |||
TLR7 | 0.048 (1.96 × 10− 4‒0.104) | 0.017 (6.63 × 10− 5‒0.094) | 0.1534 | |||
TLR8 | 0.096 (0.02‒0.242) | 0.04 (2.4 × 10− 4‒0.172) | 0.1437 | |||
TLR9 | 0.009 (3.91 × 10− 4 ‒0.039) | 0.012 (4.69 × 10− 5‒0.073) | 0.2179 | |||
TLR10 | 0.017 (5.93 × 10− 4‒0.062) | 0.005 (2.71 × 10− 5‒0.02) | 0.3102 |